1-(tert-Butyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine

Catalog No.: 
ACECWL702
CAS No.: 
2304631-49-8
Molecular Formula: 
C15H28BNO2
Molecular Weight: 
265.21
1-(tert-Butyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$666.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine
IUPAC Name1-(tert-butyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine
MDL No.MFCD22548337
Molecular FormulaC15H28BNO2
Molecular Weight265.21
SMILESCC(C(C)(C)O1)(C)OB1C2=CCN(C(C)(C)C)CC2
InChI KeyZUJZVBGVJDHVQA-UHFFFAOYSA-N
SynonymPyridine, 1-(1,1-dimethylethyl)-1,2,3,6-tetrahydro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.2304631-49-8

Synthetic Route by SureRoute

1. ACECWL702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  4. Then
  5. ACECWL702 route product structure diagram
    ACECWL7022304631-49-8
Inquiry

2. ACECWL702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  4. Then
  5. ACECWL702 route product structure diagram
    ACECWL7022304631-49-8
Inquiry

3. ACECWL702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACECWL702 route product structure diagram
    ACECWL7022304631-49-8
Inquiry

Comments (0)